134 related articles for article (PubMed ID: 16039115)
1. Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.
Kawa S; Yoshizawa K; Nikaido T; Kiyosawa K
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):173-7. PubMed ID: 16039115
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines.
Kawa S; Yoshizawa K; Tokoo M; Imai H; Oguchi H; Kiyosawa K; Homma T; Nikaido T; Furihata K
Gastroenterology; 1996 May; 110(5):1605-13. PubMed ID: 8613068
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines.
Kawa S; Nikaido T; Aoki Y; Zhai Y; Kumagai T; Furihata K; Fujii S; Kiyosawa K
Br J Cancer; 1997; 76(7):884-9. PubMed ID: 9328147
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect of 1α,25-dihydroxyvitamin D3 involves upregulation of cyclin-dependent kinase inhibitor p21 in human pancreatic cancer cells.
Kanemaru M; Maehara N; Chijiiwa K
Hepatogastroenterology; 2013; 60(125):1199-205. PubMed ID: 23803383
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
[TBL] [Abstract][Full Text] [Related]
7. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
[TBL] [Abstract][Full Text] [Related]
11. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro.
Colston KW; James SY; Ofori-Kuragu EA; Binderup L; Grant AG
Br J Cancer; 1997; 76(8):1017-20. PubMed ID: 9376260
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.
Albrechtsson E; Jonsson T; Möller S; Höglund M; Ohlsson B; Axelson J
Pancreatology; 2003; 3(1):41-6. PubMed ID: 12649563
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
Wu G; Fan RS; Li W; Ko TC; Brattain MG
Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407
[TBL] [Abstract][Full Text] [Related]
15. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
[TBL] [Abstract][Full Text] [Related]
16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3.
Schwartz GG; Eads D; Rao A; Cramer SD; Willingham MC; Chen TC; Jamieson DP; Wang L; Burnstein KL; Holick MF; Koumenis C
Carcinogenesis; 2004 Jun; 25(6):1015-26. PubMed ID: 14742320
[TBL] [Abstract][Full Text] [Related]
19. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
[TBL] [Abstract][Full Text] [Related]
20. 19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo.
Schwartz GG; Eads D; Naczki C; Northrup S; Chen T; Koumenis C
Cancer Biol Ther; 2008 Mar; 7(3):430-6. PubMed ID: 18094617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
